What is Deccan Hematolink 3.0?

Deccan Hematolink 3.0 is the largest international conference focused on AI-driven advancements in blood cancer diagnosis and treatment.

What are the growing concerns about blood cancers?

There is a growing prevalence of blood cancers, especially in urban areas, necessitating urgent early detection, advanced treatment, and wider access to care.

Home / Health / AI Revolutionizes Blood Cancer Diagnosis

AI Revolutionizes Blood Cancer Diagnosis

Q: Who attended the Deccan Hematolink 3.0 conference?

The conference brought together more than 700 hematologists and oncologists from India and overseas to discuss blood cancer management.

21 Feb

•

Summary

Deccan Hematolink 3.0 conference focused on AI in blood cancer care.
Over 700 hematologists and oncologists attended the event.
Blood cancer cases are rising, especially in urban areas.

AI Revolutionizes Blood Cancer Diagnosis

The largest international conference on AI-driven advancements in blood cancer diagnosis and treatment, Deccan Hematolink 3.0, was recently inaugurated in Hyderabad. Dr. G. S. Rao of Yashoda Group Hospitals opened the event.

The conference addressed the rising incidence of blood cancers like leukaemia, lymphoma, and myeloma, particularly in urban centers, emphasizing the urgent need for early detection and enhanced treatment options.

More than 700 hematologists and oncologists from India and abroad gathered to discuss emerging technologies and evolving clinical practices in managing blood disorders.

Discussions also covered the broader challenges patients face, including psychological stress and financial strain, highlighting the importance of community awareness and robust support systems.

Rapid medical science advancements are significantly transforming patient care, offering improved outcomes where treatment options were once limited.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.